Teleflex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Teleflex and other ETFs, options, and stocks.

About TFX

Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia Pacific. 

CEO
Jason Weidman
CEOJason Weidman
Employees
15,500
Employees15,500
Headquarters
Wayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded
1943
Founded1943
Employees
15,500
Employees15,500

TFX Key Statistics

Market cap
5.80B
Market cap5.80B
Price-Earnings ratio
-5.86
Price-Earnings ratio-5.86
Dividend yield
1.04%
Dividend yield1.04%
Average volume
640.39K
Average volume640.39K
High today
$137.02
High today$137.02
Low today
$131.49
Low today$131.49
Open price
$131.61
Open price$131.61
Volume
681.19K
Volume681.19K
52 Week high
$145.00
52 Week high$145.00
52 Week low
$100.18
52 Week low$100.18

Stock Snapshot

Teleflex(TFX) stock is priced at $136.58, giving the company a market capitalization of 5.8B. It carries a P/E multiple of -5.86 and pays a dividend yield of 1.04%.

During the trading session on 2026-10-23, Teleflex(TFX) shares reached a daily high of $137.02 and a low of $131.49. At a current price of $136.58, the stock is +3.9% higher than the low and still -0.3% under the high.

Trading activity shows a volume of 681.19K, compared to an average daily volume of 640.39K.

Over the past 52 weeks, Teleflex(TFX) stock has traded between a high of $145.00 and a low of $100.18.

Over the past 52 weeks, Teleflex(TFX) stock has traded between a high of $145.00 and a low of $100.18.

TFX News

MarketWatch 8h
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
TipRanks 19h
Teleflex announces FDA Breakthrough Device Designation for Freesolve RMS

Teleflex (TFX) announced that the U.S. FDA has granted Breakthrough Device Designation for its Freesolve Resorbable Magnesium Scaffold for percutaneous coronary...

Simply Wall St 4d
Teleflex Completes BIOMAG LL Enrollment, Is The Stock Still A Bargain?

Teleflex (TFX) stock is back in focus after the company reported full patient enrollment in its BIOMAG-LL Clinical Study, a premarket trial assessing the Freeso...

Teleflex Completes BIOMAG LL Enrollment, Is The Stock Still A Bargain?

Analyst ratings

60%

of 15 ratings
Buy
40%
Hold
60%
Sell
0%

More TFX News

TipRanks 7d
Teleflex: Underappreciated ORSIRO Growth and Stronger Execution Underscore Maintained Buy Rating and Unchanged $158 Price Target

Travis Steed, an analyst from Bank of America Securities, maintained the Buy rating on Teleflex. The associated price target remains the same with $158.00. Tra...

People also own

Based on the portfolios of people who own TFX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.